Endonovo Therapeutics Inc (ENDV)

[Cornerstone_Marketing]

The simple fact that top end universities like Stanford and Columbia are running studies without compensation are proof that the device has merit.
Not to mention literally dozens of completed studies that have showed promise.
With a device such as this that can be used to treat more than one type of injury it’s important to study it in a varied environment under many conditions to determine best use.
This will result in many positive results as well as some average results.
The idea is to determine best use.
The fact this is IN USE at VA hospitals already in more than proof enough of its viability in the marketplace.
What remains to be seen is it’s expansion into the telehealth and future DTC marketplace which should finally give the company the revenues results to make strides forward.